Altimmune, Inc. — Director's Dealing 2020

Dec 3, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Altimmune, Inc. (ALT)
CIK: 0001326190
Period of Report: 2020-11-30

Reporting Person: Garg Vipin K (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-30	Common Stock, par value $0.0001	F	2243	$12.23	Disposed	317501	Direct

Footnotes

F1: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of restricted stock.